Cargando…

Aurantoside C Targets and Induces Apoptosis in Triple Negative Breast Cancer Cells

Triple negative breast cancer (TNBC) is a subtype of breast cancers that currently lacks effective targeted therapy. In this study, we found that aurantoside C (C828), isolated from the marine sponge Manihinea lynbeazleyae collected from Western Australia, exhibited higher cytotoxic activities in TN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shrestha, Sumi, Sorolla, Anabel, Fromont, Jane, Blancafort, Pilar, Flematti, Gavin R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213655/ https://www.ncbi.nlm.nih.gov/pubmed/30275391 http://dx.doi.org/10.3390/md16100361

Ejemplares similares

Crambescidin 800, Isolated from the Marine Sponge Monanchora viridis, Induces Cell Cycle Arrest and Apoptosis in Triple-Negative Breast Cancer Cells
por: Shrestha, Sumi, et al.
Publicado: (2018)

Aurantoside J: a New Tetramic Acid Glycoside from Theonella swinhoei. Insights into the Antifungal Potential of Aurantosides
por: Angawi, Rihab F., et al.
Publicado: (2011)

Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers?
por: Marqués, Marta, et al.
Publicado: (2022)

Applications of CRISPR Technology to Breast Cancer and Triple Negative Breast Cancer Research
por: Pont, Mariona, et al.
Publicado: (2023)

Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers
por: Wang, Edina, et al.
Publicado: (2018)

Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer
por: Duffy, Ciara, et al.
Publicado: (2020)

Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer
por: Waryah, Charlene, et al.
Publicado: (2023)

Aurantoside K, a New Antifungal Tetramic Acid Glycoside from a Fijian Marine Sponge of the Genus Melophlus
por: Kumar, Rohitesh, et al.
Publicado: (2012)

Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics
por: Sorolla, Anabel, et al.
Publicado: (2019)

Targeting MYC for triple-negative breast cancer treatment
por: Klauber-DeMore, Nancy, et al.
Publicado: (2018)

Editorial: Transcription Factors Drivers of Malignancy, Progression and Poor Outcomes in Breast Cancer
por: Parisi, Eva, et al.
Publicado: (2022)

Targeting EGFR in Triple Negative Breast Cancer
por: Ueno, Naoto T., et al.
Publicado: (2011)

Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells
por: O’Grady, Shane, et al.
Publicado: (2022)

Type-I Hemins and Free Porphyrins from a Western Australian Sponge Isabela sp.
por: Sala, Samuele, et al.
Publicado: (2023)

Design and Characterization of a Cell-Penetrating Peptide Derived from the SOX2 Transcription Factor
por: Gandhi, Neha S., et al.
Publicado: (2021)

Targeting triple-negative breast cancers with the Smac-mimetic birinapant
por: Lalaoui, Najoua, et al.
Publicado: (2020)

High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target
por: Bousquet, Guilhem, et al.
Publicado: (2019)

Triple-negative breast cancer and the potential for targeted therapy
por: Jhan, Jing-Ru, et al.
Publicado: (2017)

Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
por: Li, Ying, et al.
Publicado: (2021)

Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses
por: Green-Tripp, Gabriela, et al.
Publicado: (2022)

Determinants of Sensitivity to Radiotherapy in Endometrial Cancer
por: Sorolla, Maria Alba, et al.
Publicado: (2020)

Survival Study of Triple-Negative and Non–Triple-Negative Breast Cancer in a Brazilian Cohort
por: Gonçalves, Homero, et al.
Publicado: (2018)

Novel Galiellalactone Analogues Can Target STAT3 Phosphorylation and Cause Apoptosis in Triple-Negative Breast Cancer
por: Ko, Hyejin, et al.
Publicado: (2019)

MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147
por: Wang, Cheng, et al.
Publicado: (2019)

Icariin Induces Triple-Negative Breast Cancer Cell Apoptosis and Suppresses Invasion by Inhibiting the JNK/c-Jun Signaling Pathway
por: Gao, Shenghan, et al.
Publicado: (2023)

TNF-α Gene Knockout in Triple Negative Breast Cancer Cell Line Induces Apoptosis
por: Pileczki, Valentina, et al.
Publicado: (2012)

[10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer in vivo
por: Martin, Ana Carolina B.M., et al.
Publicado: (2017)

Salicylate •Phenanthroline copper (II) complex induces apoptosis in triple-negative breast cancer cells
por: Fan, Limei, et al.
Publicado: (2017)

Varlitinib Downregulates HER/ERK Signaling and Induces Apoptosis in Triple Negative Breast Cancer Cells
por: Liu, Chun-Yu, et al.
Publicado: (2019)

Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells
por: Messeha, Samia S., et al.
Publicado: (2020)

Propofol induces ROS-mediated intrinsic apoptosis and migration in triple-negative breast cancer cells
por: Wang, Hao, et al.
Publicado: (2020)

Triple-negative breast cancer: new perspectives for targeted therapies
por: Tomao, Federica, et al.
Publicado: (2015)

CAPER as a therapeutic target for triple negative breast cancer
por: Campbell, Mallory C., et al.
Publicado: (2018)

Metformin Targets Glucose Metabolism in Triple Negative Breast Cancer
por: Wahdan-Alaswad, RS, et al.
Publicado: (2018)

Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
por: Park, So-Yeon, et al.
Publicado: (2019)

Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer
por: Nakhjavani, Maryam, et al.
Publicado: (2019)

Targeting DNA methylation for treating triple-negative breast cancer
por: Yu, Jia, et al.
Publicado: (2019)

Novel strategies to target chemoresistant triple-negative breast cancer
por: Venkatesh, Jaganathan, et al.
Publicado: (2020)

Molecular Targets and Promising Therapeutics of Triple-Negative Breast Cancer
por: Ryu, Won-Ji, et al.
Publicado: (2021)

Targeted Liposomal Chemotherapies to Treat Triple-Negative Breast Cancer
por: Si, Yingnan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rvihu42r1g5m4219k1vluqaoga